Masimo Co. (NASDAQ:MASI) Position Boosted by BlackRock Inc.

BlackRock Inc. grew its holdings in shares of Masimo Co. (NASDAQ:MASI) by 5.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,316,524 shares of the medical equipment provider’s stock after purchasing an additional 418,292 shares during the period. BlackRock Inc. owned approximately 0.15% of Masimo worth $2,231,987,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also bought and sold shares of the company. Harvest Investment Services LLC boosted its holdings in shares of Masimo by 2.7% in the fourth quarter. Harvest Investment Services LLC now owns 1,841 shares of the medical equipment provider’s stock worth $494,000 after buying an additional 48 shares during the period. First Citizens Bank & Trust Co. boosted its holdings in shares of Masimo by 3.7% in the fourth quarter. First Citizens Bank & Trust Co. now owns 1,398 shares of the medical equipment provider’s stock worth $375,000 after buying an additional 50 shares during the period. Csenge Advisory Group boosted its holdings in shares of Masimo by 2.5% in the fourth quarter. Csenge Advisory Group now owns 2,080 shares of the medical equipment provider’s stock worth $558,000 after buying an additional 51 shares during the period. Oak Ridge Investments LLC boosted its holdings in shares of Masimo by 1.2% in the third quarter. Oak Ridge Investments LLC now owns 4,422 shares of the medical equipment provider’s stock worth $1,044,000 after buying an additional 54 shares during the period. Finally, Treasurer of the State of North Carolina boosted its holdings in shares of Masimo by 0.3% in the fourth quarter. Treasurer of the State of North Carolina now owns 18,762 shares of the medical equipment provider’s stock worth $5,035,000 after buying an additional 60 shares during the period. Institutional investors own 81.64% of the company’s stock.

In other news, CEO Joe E. Kiani sold 9,034 shares of Masimo stock in a transaction that occurred on Monday, January 11th. The shares were sold at an average price of $280.45, for a total value of $2,533,585.30. Following the transaction, the chief executive officer now owns 179,241 shares of the company’s stock, valued at $50,268,138.45. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Craig B. Reynolds sold 10,000 shares of Masimo stock in a transaction that occurred on Monday, January 11th. The shares were sold at an average price of $279.74, for a total transaction of $2,797,400.00. Following the completion of the transaction, the director now directly owns 14,300 shares in the company, valued at approximately $4,000,282. The disclosure for this sale can be found here. In the last three months, insiders sold 124,273 shares of company stock worth $33,575,334. Insiders own 11.50% of the company’s stock.

MASI has been the subject of several recent analyst reports. Stifel Nicolaus raised their target price on shares of Masimo from $255.00 to $276.00 and gave the stock a “buy” rating in a report on Wednesday, October 28th. Raymond James raised their target price on shares of Masimo from $275.00 to $285.00 and gave the stock an “outperform” rating in a report on Friday, January 29th. Finally, Piper Sandler raised their price target on shares of Masimo from $280.00 to $310.00 and gave the stock an “overweight” rating in a report on Thursday, January 14th. Three research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Masimo has an average rating of “Buy” and a consensus target price of $262.14.

Shares of MASI opened at $273.52 on Wednesday. The firm has a market cap of $15.06 billion, a PE ratio of 71.04, a PEG ratio of 3.79 and a beta of 0.87. The firm’s 50 day moving average price is $266.39 and its 200 day moving average price is $244.36. Masimo Co. has a twelve month low of $143.90 and a twelve month high of $284.86.

Masimo Profile

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Featured Article: Dividend Kings

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.